Endurant Capital Management LP Athenex, Inc. Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.12 - $0.21 $45,070 - $78,872
375,585 Added 71.32%
902,236 $135,000
Q3 2022

Nov 14, 2022
BUY
$0.24 - $1.11 $126,396 - $584,582
526,651 New
526,651 $142,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email